Terms: = Colorectal cancer AND TPR, P12270, 7175
32 results:
1. Identification of MKI67, tpr , and TCHH Mutations as Prognostic Biomarkers for Patients With Defective Mismatch Repair Colon cancer Stage II/III.
Lv J; Li W; Wang X; Guo L; Wang D; Zhang Y; Yu J; Chen T; Niu B; Wang X; Liu Z
Dis Colon Rectum; 2023 Nov; 66(11):1481-1491. PubMed ID: 37643197
[TBL] [Abstract] [Full Text] [Related]
2. A retrospective study of colonoscopic surveillance in the elderly.
McGuinness MJ; Joseph N; Richards SJG; Speight JM
ANZ J Surg; 2023 Sep; 93(9):2138-2142. PubMed ID: 36811312
[TBL] [Abstract] [Full Text] [Related]
3. The non-invasive diagnosis of colorectal cancer via a SOX9-based gene panel.
Xue VW; Ng SSM; Tsang HF; Wong HT; Leung WW; Wong YN; Wong YKE; Yu ACS; Yim AKY; Cho WCS; Tai WCS; Wong SCC
Clin Exp Med; 2023 Oct; 23(6):2421-2432. PubMed ID: 36637582
[TBL] [Abstract] [Full Text] [Related]
4. Correcting rotational error in rectal cancer radiation therapy: Can planning target volume margins be safely reduced?
Seah V; Dundas K; Hudson F; Surjan Y; Bartlett R; Ko R; Smith S; Arumugam S; Johnston M; Wong K; Lee M
J Med Radiat Sci; 2022 Dec; 69(4):473-483. PubMed ID: 35715996
[TBL] [Abstract] [Full Text] [Related]
5. Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.
Antoniotti C; Rossini D; Pietrantonio F; Catteau A; Salvatore L; Lonardi S; Boquet I; Tamberi S; Marmorino F; Moretto R; Ambrosini M; Tamburini E; Tortora G; Passardi A; Bergamo F; Kassambara A; Sbarrato T; Morano F; Ritorto G; Borelli B; Boccaccino A; Conca V; Giordano M; Ugolini C; Fieschi J; Papadopulos A; Massoué C; Aprile G; Antonuzzo L; Gelsomino F; Martinelli E; Pella N; Masi G; Fontanini G; Boni L; Galon J; Cremolini C;
Lancet Oncol; 2022 Jul; 23(7):876-887. PubMed ID: 35636444
[TBL] [Abstract] [Full Text] [Related]
6. NTRK oncogenic fusions are exclusively associated with the serrated neoplasia pathway in the colorectum and begin to occur in sessile serrated lesions.
Kim JH; Hong JH; Choi YL; Lee JA; Seo MK; Lee MS; An SB; Sung MJ; Cho NY; Kim SS; Shin YK; Kim S; Kang GH
J Pathol; 2021 Dec; 255(4):399-411. PubMed ID: 34402529
[TBL] [Abstract] [Full Text] [Related]
7. NTRK fusion in Japanese colorectal adenocarcinomas.
Yamashiro Y; Kurihara T; Hayashi T; Suehara Y; Yao T; Kato S; Saito T
Sci Rep; 2021 Mar; 11(1):5635. PubMed ID: 33707574
[TBL] [Abstract] [Full Text] [Related]
8. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive colorectal Screening Tests.
Pickhardt PJ; Correale L; Hassan C
AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
[No Abstract] [Full Text] [Related]
9. cancer-related SRCAP and tpr mutations in colon cancers.
Moon SW; Mo HY; Choi EJ; Yoo NJ; Lee SH
Pathol Res Pract; 2021 Jan; 217():153292. PubMed ID: 33307343
[TBL] [Abstract] [Full Text] [Related]
10. Inhibition of MEK1/2 Forestalls the Onset of Acquired Resistance to Entrectinib in Multiple Models of NTRK1-Driven cancer.
Vaishnavi A; Scherzer MT; Kinsey CG; Parkman GL; Truong A; Ghazi P; Schuman S; Battistone B; Garrido-Laguna I; McMahon M
Cell Rep; 2020 Aug; 32(5):107994. PubMed ID: 32755586
[TBL] [Abstract] [Full Text] [Related]
11. cancer-derived UTX tpr mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.
Kato H; Asamitsu K; Sun W; Kitajima S; Yoshizawa-Sugata N; Okamoto T; Masai H; Poellinger L
Oncogene; 2020 Apr; 39(16):3322-3335. PubMed ID: 32071397
[TBL] [Abstract] [Full Text] [Related]
12. NTRK gene rearrangements are highly enriched in MLH1/PMS2 deficient, BRAF wild-type colorectal carcinomas-a study of 4569 cases.
Chou A; Fraser T; Ahadi M; Fuchs T; Sioson L; Clarkson A; Sheen A; Singh N; Corless CL; Gill AJ
Mod Pathol; 2020 May; 33(5):924-932. PubMed ID: 31792356
[TBL] [Abstract] [Full Text] [Related]
13. Colonic Adenocarcinomas Harboring NTRK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 16 Cases and Review of the Literature.
Lasota J; Chłopek M; Lamoureux J; Christiansen J; Kowalik A; Wasąg B; Felisiak-Gołąbek A; Agaimy A; Biernat W; Canzonieri V; Centonze G; Chmielik E; Daum O; Dubová M; Dziuba I; Goertz S; Góźdź S; Guttmejer-Nasierowska A; Haglund C; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kita P; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ristimäki A; Ryś J; Szostak B; Szpor J; Szumiło J; Teresiński L; Waloszczyk P; Wejman J; Wesołowski W; Miettinen M
Am J Surg Pathol; 2020 Feb; 44(2):162-173. PubMed ID: 31567189
[TBL] [Abstract] [Full Text] [Related]
14. Large-Scale Genome-Wide Association Study of East Asians Identifies Loci Associated With Risk for colorectal cancer.
Lu Y; Kweon SS; Tanikawa C; Jia WH; Xiang YB; Cai Q; Zeng C; Schmit SL; Shin A; Matsuo K; Jee SH; Kim DH; Kim J; Wen W; Shi J; Guo X; Li B; Wang N; Zhang B; Li X; Shin MH; Li HL; Ren Z; Oh JH; Oze I; Ahn YO; Jung KJ; Conti DV; Schumacher FR; Rennert G; Jenkins MA; Campbell PT; Hoffmeister M; Casey G; Gruber SB; Gao J; Gao YT; Pan ZZ; Kamatani Y; Zeng YX; Shu XO; Long J; Matsuda K; Zheng W
Gastroenterology; 2019 Apr; 156(5):1455-1466. PubMed ID: 30529582
[TBL] [Abstract] [Full Text] [Related]
15. The Prognostic Significance of Histone Demethylase UTX in Esophageal Squamous Cell Carcinoma.
Li SH; Lu HI; Huang WT; Tien WY; Lan YC; Lin WC; Tsai HT; Chen CH
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29351209
[TBL] [Abstract] [Full Text] [Related]
16. KATZLDA: KATZ measure for the lncRNA-disease association prediction.
Chen X
Sci Rep; 2015 Nov; 5():16840. PubMed ID: 26577439
[TBL] [Abstract] [Full Text] [Related]
17. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.
Cremolini C; Loupakis F; Antoniotti C; Lupi C; Sensi E; Lonardi S; Mezi S; Tomasello G; Ronzoni M; Zaniboni A; Tonini G; Carlomagno C; Allegrini G; Chiara S; D'Amico M; Granetto C; Cazzaniga M; Boni L; Fontanini G; Falcone A
Lancet Oncol; 2015 Oct; 16(13):1306-15. PubMed ID: 26338525
[TBL] [Abstract] [Full Text] [Related]
18. Chromosomal rearrangements involving the NTRK1 gene in colorectal carcinoma.
Créancier L; Vandenberghe I; Gomes B; Dejean C; Blanchet JC; Meilleroux J; Guimbaud R; Selves J; Kruczynski A
Cancer Lett; 2015 Aug; 365(1):107-11. PubMed ID: 26001971
[TBL] [Abstract] [Full Text] [Related]
19. The subcellular distribution and function of MTA1 in cancer differentiation.
Liu J; Xu D; Wang H; Zhang Y; Chang Y; Zhang J; Wang J; Li C; Liu H; Zhao M; Lin C; Zhan Q; Huang C; Qian H
Oncotarget; 2014 Jul; 5(13):5153-64. PubMed ID: 24970816
[TBL] [Abstract] [Full Text] [Related]
20. Met receptor-induced Grb2 or Shc signals both promote transformation of intestinal epithelial cells, albeit they are required for distinct oncogenic functions.
Pomerleau V; Landry M; Bernier J; Vachon PH; Saucier C
BMC Cancer; 2014 Apr; 14():240. PubMed ID: 24708867
[TBL] [Abstract] [Full Text] [Related]
[Next]
